Organisation paid for research Program year 2021 Source: CMS Open Payments

Centex Studies Incorporated

Neither a doctor nor a teaching hospital

Research payments

$1,318,296

265 payments

Through program year 2021, Centex Studies Incorporated is reported as receiving $1,318,296 in research payments, across 265 payments.

By program year

2 rows
Year Kind Amount Payments
2021 Research $200 1
2019 Research $1,318,096 264

Breakdown

Who paid Research payments · program years 2019–2021
  1. Allergan Inc. $1,318,296 265 payments
Studies the money was for Research payments · program years 2019–2021
  1. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis. $1,296,464 259 payments
  2. Open-Label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis Nash $8,950 1 payment
  3. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant for the Prevention of Migraine in Patients With Episodic Migraine $8,040 2 payments
  4. A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double- Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis $3,882 1 payment
  5. A 52-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active- Controlled, Operationally Seamless Phase 2B3, Parallel-Group Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Crohns Disease $760 1 payment
  6. A Phase 3, Multicenter, Open-Label 40-Week Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine $200 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record